PDE2A and glioblastoma: The results of the UALCAN database showed that in GBM, the protein expression of APOC1, F2R, PTBP1, NCAPG, and IFI30 significantly increased, while the protein expression of PDE2A significantly decreased (Supplementary Figure 3C).